It’s In the News! This week’s top diabetes headlines and stories include: cybersecurity risk cited for some Medtronic pumps, Omnipod 5 gets European approval, new data about the Freestyle Libre and avoiding hospitalizations, the new T1D Index and more! Check out Stacey’s book: The World’s Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign…
It’s In the News! This week’s top diabetes headlines and stories include: with more cases of type 1 and type 2 diabetes in US kids, researchers look into whether more screenings should take place. There’s a new injectable on the market that some studies show can reduce the risk of type 2 diabetes in overweight…
It’s in the news! The top stories and headlines around the diabetes community this week include: A new way to sneak islet cells into the body without needing immunosuppressive drugs, routinely checking young children for T1D markets before symptoms show up, a non invasive way to measure blood glucose uses Radio Frequency, a DIY movement…
It’s in the news! The top stories and headlines around the diabetes community this week include new progress in the quest for oral insulin to treat type 1, a new study says a common type 2 diabetes drug may help those with serious heart condition, a look at teen brains and T1D, NSAID and type…
It’s in the news! The top stories and headlines around the diabetes community this week include a new attempt to have fewer misdiagnoses of type 2 (when it’s really type 1) diabetes, a new approval for Omnipod 5 down to two years old, a look at the endocrinologist shortage in the US, a milestone for…
It’s in the news! The top stories and headlines around the diabetes community this week include: People on Medicare should see insulin prices capped, A look at whether the tuberculosis vaccine prevented Covid in people with type 1 diabetes, Tandem’s CEO has some news about their tiny Mobi pump, students create non-invasive glucose monitoring, and…
Get caught up on the news and headlines around the diabetes community! The top stories in the last seven days: Senate Republicans nixed an insulin copay cap, but Democrats say they will revisit this issue in a few weeks, Dexcom pushed back their G7 timeline in the USA after the FDA asks for changes, once…
It’s In the News! The tops diabetes stories this week include: Australian scientists say they have a new way to restore insulin production using an existing and approved drug, Tandem rolls out bolus by phone for wider release and acquires Capillary Biomedical, an infusion set maker. Dexcom adds Spanish as a language option for the…
Top stories In the News this week, United Healthcare announces changes to how they cover insulin for some, a new study looks at CGM use in people with type 2 over the age of 65, another company begins islet cell clinical trials, a new tool to treat diabetic neuropathy pain, gestational diabetes is on the…
Top stories in this news this week: Stem cell research Vertex company buys Viacyte, another company looking at stem cells for a functional cure for T1D, some tslim users are getting access to Tandem’s new mobile bolus feature, One Drop shows a “health sensor” on its website, a study shows that screening for type 1…